Immune Thrombocytopenic Purpura

Clinical syndrome in which a decreased number of circulating platelets manifests as a bleeding tendency, causing petechiae, ecchymoses, purpura and bleeding from venepuncture sites, nose etc., in an otherwise healthy patient

Aetiology

  • May occur in isolation (primary ITP) or in association with other disorders (secondary)
  • Causes of secondary ITP include:
    • Other autoimmune disorders (including antiphospholipid antibody syndrome and systemic lupus erythematosus)
    • Viral infections (including cytomegalovirus, varicella-zoster, hepatitis C and HIV)
    • Infection with Helicobacter pylori
    • Medication
    • Lymphoproliferative disorders

Pathophysiology

  • Caused by a type II hypersensitivity reaction
    • It is caused by the production of antibodies that target and destroy platelets
    • This can happen spontaneously, or it can be triggered by something, such as a viral infection

Clinical presentation

  • Usually present in children under 10 years old
  • Often there is a history of a recent viral illness
  • The onset of symptoms occurs over 24-48 hours:
    • Bleeding, for example from the gums, epistaxis or menorrhagia
    • Bruising
    • Petechial or purpuric rash, caused by bleeding under the skin

Investigations

  • FBC - isolated thrombocytopenia

Management

  • Usually no treatment is required and patients are monitored until the platelets return to normal
  • Around 70% of patients will remit spontaneously within 3 months
  • Treatment may be required if the patient is actively bleeding or severe thrombocytopenia (platelets below 10):
    • Prednisolone
    • IV immunoglobulins
    • Blood transfusions if required
    • Platelet transfusions only work temporarily